Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B vi

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:mokung1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Disruption of peripheral blood B-cell homeostasis and variation of surface receptors occur with certain infections and autoimmune diseases.However,the impact of antiviral therapy on B-cell alteration during chronic hepatitis B(CHB) infection remains unclear.Our study aims to document the effects of B-cell alteration in CHB patients treated with tenofovir or adefovir.
其他文献
Background:Acute-on-chronic liver failure(AoCLF) caused by acute exacerbation of chronic hepatitis B(CHB) is a serious consequence with high mortality in China,and it is important to identify biomarke
会议
Background:Liver stiffness measurement(LSM) by Vibration Controlled Transient Elastography(VCTE) has been shown to be influenced by necro-inflammation,which leads to incorrect diagnosis of cirrhosis e
会议
Background:To determine the serological and virological characteristics of pregnant women infected with hepatitis B virus(HBV),and valuate the efficacy and safety of telbivudine(LdT) for preventing HB
会议
Background:Chronic hepatitis B virus infection leads to cirrhosis and hepatocellular carcinoma(HCC).Most risk factors associated with HCC have been identified and models have been published to predict
会议
Background:With wide use of vaccination and antiviral agents,epidemiologic characteristics of hepatitis B virus(HBV)-infected patients have changed substantially for several decades in Korea.
会议
Background:To investigated the short term efficacies of telbivudine and entecavir as first-line agents for Hepatitis B virus(HBV) suppression in patients with HBV-related advanced Hepatocellular carci
会议
Background:Hepatitis B virus is endemic in Korea with greater that 90 %infected with genotype c.Entecavir(ETV) is a potent nucleoside analogue with high genetic barrier to resistance which has been a
会议
Background:To investigate the clinical characteristics and outcome of HBV reactivation in hepatitis B surface antigen(HBsAg)-negative and hepatitis B core antibody(anti-HBc)-positive patients with hem
会议
Background:Entecavair(ETV) 1mg monotherapy was sometimes used for the chronic hepatitis B(CHB)patients with other nucleoside resistance in the past,but now,not recommended due to sequential resistance
会议
In patients with chronic liver diseases,identification of significant liver fibrosis and cirrhosis is essential for determining treatment strategies,assessing therapeutic response,and stratifying long
会议